Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection.

MLA

Mondi, Annalisa, et al. “Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection.” Pharmaceuticals (14248247), vol. 15, no. 4, Apr. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/ph15040403.

APA

Mondi, A., Pinnetti, C., Lorenzini, P., Plazzi, M. M., Abbate, I., Camici, M., Agrati, C., Grilli, E., Gili, F., Esvan, R., Orchi, N., Rozera, G., Amendola, A., Forbici, F., Gori, C., Gagliardini, R., Bellagamba, R., Ammassari, A., Cicalini, S., & Capobianchi, M. R. (2022). Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection. Pharmaceuticals (14248247), 15(4), N.PAG. https://doi.org/10.3390/ph15040403

Chicago

Mondi, Annalisa, Carmela Pinnetti, Patrizia Lorenzini, Maria Maddalena Plazzi, Isabella Abbate, Marta Camici, Chiara Agrati, et al. 2022. “Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection.” Pharmaceuticals (14248247) 15 (4): N.PAG. doi:10.3390/ph15040403.